Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool as read-only and idempotent, but the description adds substantial extra behavior: unresolved identifiers are stated under 'unresolved' instead of omitted, ambiguous matches return 'figi_candidates' and assert nothing, and LEI/FIGI enrichment 'degrades gracefully' if external sources are down. This is exactly the kind of context agents need beyond structured hints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with the core purpose and organized under SUPPORTED TYPES with sub-details for company and drug resolution. Some parentheticals are heavy, but the complexity of the domain justifies much of the length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given there is no output schema, the description compensates well by explaining return semantics: labeled source identifiers, unresolved fields, figi_candidates for ambiguity, and graceful degradation. For a two-parameter, read-only lookup tool, an agent has enough context to invoke it correctly in diverse situations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds meaningful nuance beyond the schema: ISIN is accepted as an input form, and it warns agents to pass the entity name only, not the full noun phrase, because 'trailing security-class words match nothing'. This materially improves invocation correctness.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user-phrase examples and a specific verb+resource: 'resolve a user-spoken NAME to the canonical/official identifiers'. It clearly distinguishes the tool's purpose from siblings by stating that these identifiers are what 'other tools require as input'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit usage rule: 'Use FIRST whenever you have a name but need an ID.' It also enumerates supported entity types and input forms, which helps agents route requests. It does not explicitly name alternative tools or state when not to use this tool, so it falls just short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation4/5

The 11 fb_* Facebook tools are clearly separated by resource (account vs campaign vs adset) and action (list vs get vs create), and the Pipeworx research tools each have distinct roles (router, grounded, profile, compare, research). However, ask_pipeworx, ask_pipeworx_beta, and deep_research overlap in routing/fan-out behavior, and ai_visibility_check vs scan_competitor_ai_presence are near-identical in purpose, creating some ambiguity.

Naming Consistency3/5

The 11 fb_* tools follow a consistent fb_verb_noun pattern (except fb_get_campaign vs fb_list_*), but the remaining 25+ tools mix verb-first (ask_pipeworx, compare_entities, resolve_entity), noun-first (entity_profile, recent_changes, polymarket_edges), and generic names (forget, recall, remember). Pipeworx tools use verb_noun mostly consistently (ask_pipeworx, discover_tools, resolve_entity) but the overall set blends two naming cultures without a unifying prefix or pattern.

Tool Count3/5

36 tools is on the heavy side for one server. The Facebook ads domain only needs ~11 tools, while the rest are a sprawling Pipeworx research/meta platform (memory, subscription, prediction-market, web-tooling, AI-visibility) that feels like several servers merged into one. Each area is internally coherent, but as a single MCP server the count is bloated.

Completeness4/5

The Facebook ads surface covers list accounts/campaigns/adsets and read campaigns/insights, but notably lacks create/update/delete operations for campaigns and adsets, so the ad-management workflow has dead ends. The Pipeworx research side is extremely complete for data lookup (router, grounded, deep research, entity profiles, comparisons, verification), though the memory/subscription tools introduce a separate domain that is only thinly supported.